CAVALERI DANIELE

Bartoli, F., Calabrese, A., Moretti, F., Castiglioni, M., Prestifilippo, L., De Pietra, A., et al. (2024). Exploring depression in people with schizophrenia spectrum disorders: A cross-sectional analysis of the clinical relationship with Positive and Negative Syndrome Scale dimensions. REVISTA BRASILEIRA DE PSIQUIATRIA [10.47626/1516-4446-2023-3418]. Dettaglio

Bartoli, F., Bachi, B., Callovini, T., Palpella, D., Piacenti, S., Morreale, M., et al. (2024). Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates. CNS SPECTRUMS, 29(1), 49-53 [10.1017/S1092852923002377]. Dettaglio

Cavaleri, D., Crocamo, C., Morello, P., Bartoli, F., Carra, G. (2024). The Kynurenine Pathway in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Blood Concentrations of Tryptophan and Its Catabolites. JOURNAL OF CLINICAL MEDICINE, 13(2) [10.3390/jcm13020583]. Dettaglio

Ostuzzi, G., Gastaldon, C., Tettamanti, M., Cartabia, M., Monti, I., Aguglia, A., et al. (2024). Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial. ECLINICALMEDICINE, 69(March 2024) [10.1016/j.eclinm.2024.102491]. Dettaglio

Cavaleri, D., Moretti, F., Bartoccetti, A., Mauro, S., Crocamo, C., Carrà, G., et al. (2023). The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 149(June 2023) [10.1016/j.neubiorev.2023.105159]. Dettaglio